HYPORT Adjuvant Trial Evaluates Quality of Life After Nodal Radiotherapy
8h agoen
From the article
The HYPORT Adjuvant trial provides reassuring evidence that regional nodal irradiation delivered with an ultrahypofractionated schedule of 26 Gy in five fractions does not worsen patient-reported quality of life compared […]
Continue reading on OncoDailyYou might also wanna read
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
clinicaltrials.gov·3d ago
Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer
clinicaltrials.gov·2d ago
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
clinicaltrials.gov·7d ago
Dose-reduced thoracic radiotherapy shows promise for older and frail stage III NSCLC patients in randomized trial
This randomized open-label cohort trial by Wei-Xiang Qi and colleagues investigates whether dose-reduced thoracic radiotherapy can mitigate
plos.io·1mo agoExperimental Novartis radiopharma drug shows promise in early study
reuters.com·1mo ago
Daily Adjustment of the Radiation Dose in MRI-guided Stereotactic Radiotherapy for Tumors in the Abdominal and Pelvic Regions
clinicaltrials.gov·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.